Trial Details
UNKNOWNBasic Information
| Clinical ID | c1754 |
|---|---|
| Identifier | NCT04550130 |
| Trial Title | Dose-Evaluation Study of the Efficacy and Safety of TLA Gut™ Leukapheresis Treatment in Patients With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | DEVICE: TLA Gut™ |
Participant Information
| Sponsor | TLA, Targeted Immunotherapies AB |
|---|---|
| City | Stockholm |
| Country/Region | Sweden |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2022-12 |
|---|---|
| Primary Completion Date | 2023-04 |
| Completion Date | 2023-12 |